SARAH EGGE

Value-based care, Medicare Advantage

Value-based care and value of integrated delivery systems; appropriate use of AI in health care; workforce issues; affordability issues

Value of prescription drugs and patient access Issues related to Medicaid, Medicare Parts B & D, MFN U.S. Competitiveness issues

H.R.1476/S.694, PLASMA Act

Issues related to plasma-derived therapies in rare diseases and critical care settings

Value of prescription drugs and patient access Issues related to Medicare Parts B & D, MFN Promoting U.S. competitiveness while ensuring U.S. leadership role in developing medicines Health care workforce Clinical Trial Modernization Act

Physician payment issues, including Patients First Act (H.R.9693); access to primary care; ECAPS Act; health care access and affordability issues

RNA interference scientific advancements and rare diseases; differentiation of genetically-targeted therapies; H.R. 1672, Maintaining Investments in New Innovation Act; U.S. Competitiveness

FDA modernization

Chronic kidney disease issues; upstream kidney disease prevention; S.1552, Living Donor Protection Act; access to innovation for kidney patients

rural health access; health care affordability; Medicare physician payment; transparency

Advance the use and funding of FDA-approved medicines to treat serious mental illness; protecting patient access to mental health medications in public programs

Advance the use and funding of FDA-approved medicines to treat serious mental illness; protecting patient access to mental health medications in public programs

Medicare NCD on access to power standing systems; Prior authorization reforms to speed access for people with serious disabilities; HR 5081, DMEPOS Relief Act of 2025; HR 1703/S247 Choices for Increased Mobility Act of 2025

Implementation of HR 4993 the Joe Fiandra Access to Home Infusion Act, including issues in CMS-1828-P; Promoting US competitiveness while ensuring continued patient access to lifesaving medicines

Preserving US competitiveness and patient access to lifesaving medicines, especially for treatment of rare diseases

Value of Medicaid to health center patients; Importance of Medicare and Medicaid PPS to provide access for health center patients.

Extending Community Health Center, Teaching Health Center and National Health Service Corps funding. Telehealth extension and issues impacting health centers; Importance of nutrition support and behavioral health and substance abuse services to patients; HR 9389, Nutrition Education and Chronic Disease Prevention in Community Health Centers; HR 8201, Expanding Community Access to Health Services Act

Value-based care; appropriate use of AI in health care; workforce issues; affordability issues

Value-based care, Medicare Advantage

Issues related to plasma-derived therapies in rare diseases and critical care settings

H.R.1476/S.694, PLASMA Act

Value of prescription drugs and patient access Issues related to Medicare Parts B & D, MFN Promoting U.S. competitiveness while ensuring U.S. leadership role in developing medicines

Physician payment issues, including Patients First Act (H.R.9693); access to primary care; ECAPS Act; health care access and affordability issues

Differentiate beer from hemp; general policy regarding the regulation of the alcohol industry.

HR 1707 Grown in America Act

RNA interference scientific advancements and rare diseases; differentiation of genetically-targeted therapies; H.R. 1672, Maintaining Investments in New Innovation Act; P.L. 119-21; U.S. Competitiveness

Chronic kidney disease issues; upstream kidney disease prevention; S.1552, Living Donor Protection Act; access to innovation for kidney patients

rural health access; health care affordability; Medicare physician payment

Value of prescription drugs and patient access Issues related to Medicaid, Medicare Parts B & D, MFN U.S. Competitiveness issues

HR 4993 the Joe Fiandra Access to Home Infusion Act; Promoting US competitiveness while ensuring continued patient access to lifesaving medicines; HR 7148 the Consolidated Appropriations Act of 2026

S 932/HR 1262 Mikaela Naylon Give Kids a Chance Act of 2025; Preserving US competitiveness and patient access to lifesaving medicines; HR 7148 the Consolidated Appropriations Act of 2026

Value of Medicaid to health center patients; Importance of Medicare and Medicaid PPS to provide access for health center patients.

Extending Community Health Center, Teaching Health Center and National Health Service Corps funding. Value of Medicaid to health center patients, Telehealth extension and issues impacting health centers; HR 7148 the Consolidated Appropriations Act of 2026; importance of nutrition support and behavioral health and substance abuse services to patients.

Differentiate beer from hemp; general policy regarding the regulation of the alcohol industry.

HR 1707 Grown in America Act

rural health access; extensions of telehealth waivers and acute hospital care at home waiver program; H.R.7148, Consolidated Appropriations Act of 2026; health care affordability

Value-based care, Medicare Advantage

Value-based care; appropriate use of AI in health care; workforce issues; affordability issues

Physician payment issues; telehealth issues; access to primary care; expiring health provisions, H.R. 7148, Consolidated Appropriations Act, 2026

Expiring public health provisions, including teaching health center graduate medical education, H.R. 7148, Consolidated Appropriations Act, 2026

Value of prescription drugs and patient access Issues related to Medicare Parts B & D, MFN Promoting U.S. competitiveness while ensuring U.S. leadership role in developing medicines

Issues related to plasma-derived therapies in rare diseases and critical care settings

H.R.1476/S.694, PLASMA Act

Value of prescription drugs and patient access Issues related to Medicaid, Medicare Parts B & D, MFN U.S. Competitiveness issues

RNA interference scientific advancements and rare diseases; differentiation of genetically-targeted therapies; H.R. 1672, Maintaining Investments in New Innovation Act; P.L. 119-21; U.S. Competitiveness

Chronic kidney disease issues; upstream kidney disease prevention; S.1552, Living Donor Protection Act

Advance the use and funding of FDA-approved medicines to treat serious mental illness; protecting patient access to mental health medications in public programs

Extension of Acute Hospital Care at Home waiver program; Hospital Inpatient Services Modernization Act (H.R. 4313/S. 2237); Telehealth Modernization Act of 2025 (H.R. 5081/S. 2709); H.R. 7148, Consolidated Appropriations Act, 2026

Health care access and affordability; delivery system reform; and patient-first care.

Health care access and affordability; delivery system reform; and patient-first care.

HR 4993 the Joe Fiandra Access to Home Infusion Act; Promoting US competitiveness while ensuring continued patient access to lifesaving medicines

S 932/HR 1262 Mikaela Naylon Give Kids a Chance Act of 2025; Preserving US competitiveness and patient access to lifesaving medicines

Physician payment issues; telehealth issues; access to primary care; P.L. 119-21; expiring health provisions, including H.R. 5371, Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026

H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025, P.L. 119-44; affordability issues; expiring public health provisions, including H.R. 5371, Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026

Value of prescription drugs and patient access Issues related to Medicare Parts B & D P.L. 119-21 H.R. 946/S. 1862, ORPHAN Cures Act H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025/Public Law No: 119-44 Promoting U.S. competitiveness while ensuring U.S. leadership role in developing medicines

Extending Community Health Center, Teaching Health Center and National Health Service Corps funding. Value of Medicaid to health center patients, Telehealth extension and issues impacting health centers

Value of Medicaid to health center patients; HR 5081, Telehealth Modernization Act; payment parity in telehealth for health centers

Value-based care; appropriate use of AI in health care; workforce issues; affordability issues

Value-based care, Medicare Advantage

H.R.1476/S.694, PLASMA Act

Issues related to plasma-derived therapies in rare diseases and critical care settings

Extension of Acute Hospital Care at Home waiver program; Hospital Inpatient Services Modernization Act (H.R. 4313/S. 2237); Telehealth Modernization Act of 2025 (H.R. 5081/S. 2709); H.R. 5371, Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026

Value of prescription drugs and patient access Issues related to Medicaid, Medicare Parts B & D H.R. 1 U.S. Competitiveness issues

RNA interference scientific advancements and rare diseases; differentiation of genetically-targeted therapies; H.R. 1672, Maintaining Investments in New Innovation Act; H.R. 946/S. 1862, ORPHAN Cures Act; P.L. 119-21; U.S. Competitiveness

Chronic kidney disease issues; upstream kidney disease prevention; living donor protection issues

General health care issues related to behavioral health and integration with primary care and addressing the opioid epidemic (including H.R.2483, the Support for Patients and Communities Reauthorization Act)

rural health access; extensions of telehealth waivers and acute hospital care at home waiver program; health care affordability

Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments for substance use disorder and alcohol use disorder; Initiatives to promote the use of relapse prevention post detoxification; Advance the use and funding of FDA-approved medicines to treat serious mental illness in criminal justice and public health settings; H.R. 4030, Treatment Continuity Act of 2025

Differentiate beer from hemp; general policy regarding the regulation of the alcohol industry.

Extending Community Health Center, Teaching Health Center and National Health Service Corps funding. Value of Medicaid to health center patients; HR 2483 the SUPPORT Act

Value of Medicaid to health center patients; HR 1 (Public law 119-21); HR 5081, Telehealth Modernization Act

HR 4993 the Joe Fiandra Access to Home Infusion Act

Priority Review Voucher extension; S 932/HR 1262 Give Kids a Chance Act of 2025; S 1862/HR 946 Orphan Cures Act; Importance of patient access to treatments in HR 1 (Public Law 119-21)

Value of prescription drugs and patient access Issues related to Medicare Parts B & D P.L. 119-21 H.R. 946/S. 1862, ORPHAN Cures Act H.R. 2483, SUPPORT Act

HR 1707 Grown in America Act; Proposals to extend and change the Tax Cuts and Jobs Act (PL 119-21)

Value of prescription drugs and patient access Issues related to Medicaid, Medicare Parts B & D H.R. 1

RNA interference scientific advancements and rare diseases; differentiation of genetically-targeted therapies; H.R. 1672, Maintaining Investments in New Innovation Act; H.R. 946/S. 1862, ORPHAN Cures Act; P.L. 119-21

General health care issues related to behavioral health and integration with primary care and addressing the opioid epidemic (including H.R.2483, the Support for Patients and Communities Reauthorization Act)

rural health access; extensions of telehealth waivers and acute hospital care at home waiver program; health care affordability

Chronic kidney disease issues; upstream kidney disease prevention

Physician payment issues; telehealth; access to primary care; P.L. 119-21; expiring health provisions

H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025

Value-based care; appropriate use of AI in health care; workforce issues

Value-based care, Medicare Advantage

Extension of Acute Hospital Care at Home waiver program; Hospital Inpatient Services Modernization Act (H.R. 4313/S. 2237); Telehealth Modernization Act of 2025 (H.R. 5081/S. 2709)

Issues related to plasma-derived therapies in rare diseases and critical care settings

H.R.1476/S.694, PLASMA Act

Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments for substance use disorder and alcohol use disorder; Initiatives to promote the use of relapse prevention post detoxification; Advance the use and funding of FDA-approved medicines to treat serious mental illness in criminal justice and public health settings; H.R. 4030, Treatment Continuity Act of 2025

Value-based care; appropriate use of AI in health care

Issues related to plasma-derived therapies in rare diseases and critical care settings

H.R.1476/S.694, PLASMA Act

Extension of Acute Hospital Care at Home waiver program; Hospital Inpatient Services Modernization Act (H.R. 4313/S. 2237)

Value of prescription drugs and patient access Issues related to Medicare Parts B & D P.L. 119-21 H.R. 946/S. 1862, ORPHAN Cures Act H.R. 2483, SUPPORT Act

Physician payment issues; telehealth; access to primary care; P.L. 119-21

Value of prescription drugs and patient access Issues related to Medicaid, Medicare Parts B & D H.R. 1 H.R.946/S.1862 - ORPHAN Cures Act

RNA interference scientific advancements and rare diseases; differentiation of genetically-targeted therapies; H.R. 1672, Maintaining Investments in New Innovation Act; H.R. 946/S. 1862, ORPHAN Cures Act; P.L. 119-21

Chronic kidney disease issues; P.L. 119-21

General health care issues related to behavioral health and integration with primary care and addressing the opioid epidemic (including H.R.2483, the Support for Patients and Communities Reauthorization Act); rural health access; telehealth; P.L. 119-21

Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments for substance use disorder and alcohol use disorder; Initiatives to promote the use of relapse prevention post detoxification; Advance the use and funding of FDA-approved medicines to treat serious mental illness in criminal justice and public health settings; H.R. 4030, Treatment Continuity Act of 2025

Joe Fiandra Access to Home Infusion

Priority Review Voucher extension; S 932/HR 1262 Give Kids a Chance Act of 2025; S 1862/HR 946 Orphan Cures Act; Importance of patient access to treatments in HR 1 (Public Law 119-21)

Extending Community Health Center, Teaching Health Center and National Health Service Corps funding. Value of Medicaid to health center patients; HR 2483 the SUPPORT Act

Value of Medicaid to health center patients; HR 1 (Public law 119-21)

HR 1707 Grown in America Act; Proposals to extend and change the Tax Cuts and Jobs Act (PL 119-21)

Value-based care and appropriate use of AI in health care

HR 1968 the Full Year Continuing Appropriations and Extensions Act of 2025; Extending Community Health Center, Teaching Health Center and National Health Service Corps funding. Value of Medicaid to health center patients

Value of Medicaid to health center patients

Joe Fiandra Access to Home Infusion

Priority Review Voucher extension; S 932 Give Kids a Chance Act of 2025

Issues related to plasma-derived therapies in rare diseases and critical care settings

H.R.1476/S.694, PLASMA Act

HR 1707 Grown in America Act

Extension of Acute Hospital Care at Home waiver program; Hospital Inpatient Services Modernization Act (H.R.8260/S.4350 from 118th Congress); H.R.1968 - Full-Year Continuing Appropriations and Extensions Act, 2025

H.R.2483, SUPPORT for Patients and Communities Reauthorization Act of 2025; H.R.1968 - Full-Year Continuing Appropriations and Extensions Act, 2025

Physician payment, health care workforce and training, and telehealth issues (H.R.1968 - Full-Year Continuing Appropriations and Extensions Act, 2025)

RNA interference scientific advancements and rare diseases; differentiation of genetically-targeted therapies; H.R. 1672, Maintaining Investments in New Innovation Act; H.R. 946, ORPHAN Cures Act

General health care issues related to behavioral health and integration with primary care and addressing the opioid epidemic (including H.R.4531/S.3393, the Support for Patients and Communities Reauthorization Act); health care workforce improvements; public health improvements; H.R.1968 - Full-Year Continuing Appropriations and Extensions Act, 2025.

Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments for substance use disorder and alcohol use disorder; Initiatives to promote the use of relapse prevention post detoxification; Advance the use and funding of FDA-approved medicines to treat serious mental illness in criminal justice and public health settings.

Value-based care issues; physician workforce issues

Value-based care issues; physician workforce issues

HR 5397 the Joe Fiandra Access to Home Infusion Act, HR 5526 Seniors' Access to Critical Medications Act; HR 8816 American Medical Innovation and Investment Act; Issues related to patient access to rare disease therapies

Extension of Priority Review Vouchers in S 4583; HR 7384 the Creating Hope Reauthorization Act, FDA reforms to improve rare disease patient perspective input and flexibilities

Extension of Acute Hospital Care at Home waiver program; Hospital Inpatient Services Modernization Act (H.R.8260/S.4350); AINS to H.R.7623, the Telehealth Modernization Act; AINS to H.R.8261, the Preserving Telehealth, Hospital, and Ambulance Access Act.

Differentiate beer from cannabis; general policy regarding the regulation of the alcohol industry

Value of prescription drugs Issues related to Medicare Parts B & D Implementation of P.L. 117-169, Inflation Reduction Act of 2022

Improve integration of behavioral health and primary care; advance value-based care; address workforce shortages and improve data collection under Graduate Medical Education program; adequate physician reimbursement; issues related to Centers for Medicare and Medicaid Innovation; H.R.7623 Telehealth Modernization Act

Value of prescription drugs and patient access Issues related to Medicare Parts B & D Implementation of P.L. 117-659 (H.R.5376) - Inflation Reduction Act

RNA interference scientific advancements and rare diseases; differentiation of genetically-targeted therapies; S.476/H.R.5547, Maintaining Investments in New Innovation Act; patient access to appropriate home infusion (H.R. 5397, Joe Fiandra Access to Home Infusion Act; AINS to H.R. 8816; AINS to H.R. 5526)

Access to preventative health; HR 5378 The Lower Costs, More Transparency Act to extend funding for Community Health Centers, Teaching Health Centers GME and the National Health Service Corps; Bipartisan Primary Care and Health Workforce Act; S 2840 the Primary Care and Health Workforce Act; and other workforce improvements; HR 7623 the Telehealth Modernization Act

Extending funding for Community Health Centers and preserving and enhancing federal reimbursement methodologies; ensuring continued access to telehealth services; HR 7623 Telehealth Modernization Act; Medicare National Coverage Determination on HIV Pre-exposure Prophylaxis (PrEP)

Value of coordination and management in providing high quality, efficient health care coverage